312 related articles for article (PubMed ID: 18060357)
1. Inflammatory bowel disease: the problems of dysplasia and surveillance.
Mitchell PJ; Salmo E; Haboubi NY
Tech Coloproctol; 2007 Dec; 11(4):299-309. PubMed ID: 18060357
[TBL] [Abstract][Full Text] [Related]
2. Colorectal Cancer Screening in Inflammatory Bowel Disease.
Sengupta N; Yee E; Feuerstein JD
Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
[TBL] [Abstract][Full Text] [Related]
3. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
[TBL] [Abstract][Full Text] [Related]
4. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
[TBL] [Abstract][Full Text] [Related]
5. White light endoscopy versus chromoendoscopy for the detection of dysplasia during inflammatory bowel disease surveillance with colonoscopy.
Vaziri H; Anderson JC
Gastroenterology; 2015 Nov; 149(6):1630-2. PubMed ID: 26428464
[No Abstract] [Full Text] [Related]
6. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West).
Soetikno R; Kaltenbach T; McQuaid KR; Subramanian V; Kumar R; Barkun AN; Laine L
Dig Endosc; 2016 Apr; 28(3):266-73. PubMed ID: 26866420
[TBL] [Abstract][Full Text] [Related]
7. Cancer surveillance in inflammatory bowel disease: new molecular approaches.
Risques RA; Rabinovitch PS; Brentnall TA
Curr Opin Gastroenterol; 2006 Jul; 22(4):382-90. PubMed ID: 16760754
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of patients with inflammatory bowel disease.
Yu JX; East JE; Kaltenbach T
Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):949-958. PubMed ID: 27938789
[TBL] [Abstract][Full Text] [Related]
9. [Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
Angelberger S; Campregher C; Fuchssteiner H; Gasche C; Gröchenig HP; Haas T; Kazemi-Shirazi L; Mayer A; Miehsler W; Platzer R; Reinisch W; Steiner P; Tilg H; Tillinger W; Vogelsang H; Novacek G
Z Gastroenterol; 2013 May; 51(5):450-7. PubMed ID: 23681899
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop.
Axelrad JE; Cross RK
Am J Gastroenterol; 2023 Mar; 118(3):429-431. PubMed ID: 36584365
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer in inflammatory bowel disease: a shift in risk?
Gallinger ZR; Weizman AV
Expert Rev Anticancer Ther; 2014 Jul; 14(7):847-56. PubMed ID: 24621115
[TBL] [Abstract][Full Text] [Related]
13. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease.
Laine L; Kaltenbach T; Barkun A; McQuaid KR; Subramanian V; Soetikno R;
Gastrointest Endosc; 2015 Mar; 81(3):489-501.e26. PubMed ID: 25708752
[No Abstract] [Full Text] [Related]
14. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959
[TBL] [Abstract][Full Text] [Related]
15. Endoscopy/surveillance in inflammatory bowel disease.
Ahmadi AA; Polyak S
Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Undergoing Regular Colonoscopic Surveillance.
Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; van Bodegraven AA; Jansen JM; Mahmmod N; Kremer W; Siersema PD; Oldenburg B;
Clin Gastroenterol Hepatol; 2015 Sep; 13(9):1656-61. PubMed ID: 25956835
[TBL] [Abstract][Full Text] [Related]
17. Response to Laine et al.
Higgins PD
Am J Gastroenterol; 2015 Dec; 110(12):1735. PubMed ID: 26673506
[No Abstract] [Full Text] [Related]
18. Response to Editorial of Peter D.R. Higgins (July 2015).
Laine L; Kaltenbach T; Barkun A; McQuaid KR; Subramanian V; Soetikno R
Am J Gastroenterol; 2015 Dec; 110(12):1734-5. PubMed ID: 26673505
[No Abstract] [Full Text] [Related]
19. Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives.
Wijnands AM; Mahmoud R; Lutgens MWMD; Oldenburg B
Eur J Intern Med; 2021 Nov; 93():35-41. PubMed ID: 34481721
[TBL] [Abstract][Full Text] [Related]
20. Surveillance strategies in inflammatory bowel disease.
Schmidt C; Bielecki C; Felber J; Stallmach A
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):189-201. PubMed ID: 20485256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
